Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11992506
Stem cell derived pancreatic islet differentiation
granted -
US 11992555
Solid solution compositions and use in chronic inflammation
granted -
US 11993569
3-amino-4-halocyclopentene carboxylic acids as inactivators of aminotransferases
granted -
US 11993793
Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
granted -
US 11993594
IRAK inhibitors and method for making and using
granted -
US 11993660
Chimeric polypeptides and methods of altering the membrane localization of the same
granted -
US 11993584
Solid forms of an azolopyrimidine compound
granted -
US 11993640
Treating inflammatory lung disease
granted -
US 11993789
Pichinde virus reverse genetics systems and methods of use
granted -
AU 2022263543
Pharmaceutical compositions comprising sorbitan esters
granted -
US 2024166750
GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNCTION
granted -
US 11987628
Methods and compositions for modulating CAR-T activity
granted -
US 11987821
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
granted -
US 11987548
Methods of making bempedoic acid and compositions of the same
granted -
US 11987792
Compositions and methods for inhibiting expression of the LECT2 gene
granted -
US 11986534
Treatment of anthrax with pegylated capsule-degrading enzyme
granted -
US 11986537
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 11987590
Compounds that participate in cooperative binding and uses thereof
granted -
US 11987586
Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists
granted -
US 11986481
Method of synthesizing thyroid hormone analogs and polymorphs thereof
granted -
US 11986455
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted -
US 11986454
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted -
US 11986511
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 11986471
Compounds and methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.